ZFAS1 and hepatocellular carcinoma: Moreover, Kaplan-Meier survival analysis succeeded by a log-rank test affirmed that HCC patients possessing higher ZFAS1 levels exhibited a poorer overall survival rate than those with lower ZFAS1 levels (Fig. 1F).